Mayo Clinic Reveals Data on Rebound COVID-19 Symptoms After Paxlovid Treatment
Mayo Clinic researchers studied the outcomes of treating high-risk patients for COVID-19 with a five-day oral regimen of nirmatrelvir and ritonavir, which are together marketed as Paxlovid. Out of 483…